ARCHIVES

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

This article is from The Cancer Letter archive.

Vol. 20 No. 46 | December 2, 1994

Download PDF Visit The Full Archive

Related Articles

Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office.

November 19, 2004

U.S., France Offer Carcinogenesis Program

February 13, 1981

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000

FASEB: Focus on Research Funding, Not PR

June 14, 2013

New Risk Stratification Method For Prostate Cancer Described

November 28, 2003

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009